Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ASK: "THE LAST DON" OF MOMENTUM TRADES -- Ignore unavailable to you. Want to Upgrade?

To: findstock who wrote (753)	12/14/1998 5:35:00 PM
From: MoneyMade	Read Replies (4) \| Respond to of 15987

MEDC---NEWS (inside) MEDC should resume trading tomorrow The Med-Design Corporation Signs Multi-Product Licensing Agreements With Becton Dickinson Monday December 14, 4:19 pm Eastern Time Company Press Release SOURCE: The Med-Design Corporation VENTURA, Calif., Dec. 14 /PRNewswire/ -- The Med-Design Corporation (Nasdaq: MEDC - news), designer and developer of safety medical needle products, announced today that it has signed multi-product licensing, option and equity agreements with Becton Dickinson and Company (NYSE: BDX - news), a leading Franklin Lakes, New Jersey-based global medical technology company. These agreements, which will provide Med-Design with a multi-million dollar up-front payment plus continuing royalties, grant Becton Dickinson the exclusive worldwide rights for applications of the Company's proprietary technology in certain defined fields of use. In addition, Becton Dickinson is making a $1.5 million equity investment in Med-Design through the purchase of 300,000 shares of Convertible Preferred Stock, convertible into Med-Design's common shares at $5.00 per share. Becton Dickinson will be entitled to one seat on Med-Design's Board of Directors. James M. Donegan, Chairman and Chief Executive officer of Med-Design, commented: ''We are very pleased to be a partner with Becton Dickinson in its continued effort to assure that health care workers have access to the most advanced safety needle devices available. Becton Dickinson is exactly the kind of partner a company like ours looks for, because it understands the value of our advanced designs and is committed to putting them in the hands of doctors and nurses. We've worked hard to make the best retractable technology available, and Becton Dickinson -- with over ten years of dedication to advanced protection products -- is the ideal manufacturer to bring our designs to market.'' Gary Cohen, Executive Vice President, Becton Dickinson, said: ''This agreement supports our long-standing commitment to protect health care workers from injury and infection and to help them deliver the highest-quality patient care. Med-Design's versatile, cost-effective retractable needle systems are applicable to a broad range of products. This is the kind of design flexibility we look for when we consider how best to meet the needs of doctors, nurses, hospitals and other health care facilities.'' In addition to the products that are the subject of this agreement, Med-Design has a number of other applications of its retractable safety needle technology which are designed to enable health care workers to perform a wide range of medical procedures involving medication injection, infusion and fluid collection at greatly reduced exposure to accidental needle stick injuries. To date, Med-Design has 21 product applications in various stages of development using its retractable needle technology, and holds many U.S. and international patents and patents pending on safety needle devices designed to reduce the incidence of accidental needle stick injuries. ''Safe Harbor'' statement under Private Securities Litigation Reform Act of 1995: The information set forth above includes ''forward-looking statements'' and accordingly, the cautionary statements contained in Med-Design's Annual Report of form 10-KSB for the year ended December 31, 1997, (See Item I - Business, and Item 6 - Management's Discussion and Analysis of Plan of operation) , and other filings with the Securities and Exchange Commission are incorporated herein by reference. Med-Design's actual results may differ materially from the anticipated results and other expectations expressed in Med-Design's forward-looking statements.